668 related articles for article (PubMed ID: 24652535)
21. The tubal epigenome - An emerging target for ovarian cancer.
Reavis HD; Drapkin R
Pharmacol Ther; 2020 Jun; 210():107524. PubMed ID: 32197795
[TBL] [Abstract][Full Text] [Related]
22. Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis.
Wang Y; Huang P; Wang BG; Murdock T; Cope L; Hsu FC; Wang TL; Shih IM
Cancer Res; 2022 Dec; 82(24):4528-4541. PubMed ID: 36206311
[TBL] [Abstract][Full Text] [Related]
23. Morphological and immunohistochemical pattern of tubo-ovarian dysplasia and serous tubal intraepithelial carcinoma.
Chene G; Cayre A; Raoelfils I; Lagarde N; Dauplat J; Penault-Llorca F
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():89-95. PubMed ID: 25461359
[TBL] [Abstract][Full Text] [Related]
24. Taking the Tube: From Normal Fallopian Tube Epithelium to Ovarian High-grade Serous Carcinoma.
Tone AA
Clin Obstet Gynecol; 2017 Dec; 60(4):697-710. PubMed ID: 29045296
[TBL] [Abstract][Full Text] [Related]
25. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
[TBL] [Abstract][Full Text] [Related]
26. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
Kurman RJ; Vang R; Junge J; Hannibal CG; Kjaer SK; Shih IeM
Am J Surg Pathol; 2011 Nov; 35(11):1605-14. PubMed ID: 21997682
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high-grade serous carcinoma from fallopian tube epithelial cells: Dissection of the molecular effects.
Chu TY; Khine AA; Wu NY; Chen PC; Chu SC; Lee MH; Huang HS
Mol Carcinog; 2023 Sep; 62(9):1417-1427. PubMed ID: 37265438
[TBL] [Abstract][Full Text] [Related]
28. Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer.
Nishida N; Murakami F; Higaki K
Pathol Int; 2016 Jun; 66(6):337-42. PubMed ID: 27250113
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.
Ducie J; Dao F; Considine M; Olvera N; Shaw PA; Kurman RJ; Shih IM; Soslow RA; Cope L; Levine DA
Nat Commun; 2017 Oct; 8(1):990. PubMed ID: 29042553
[TBL] [Abstract][Full Text] [Related]
30. Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma.
Tolcher MC; Swisher EM; Medeiros F; Lima JF; Hilderbrand JL; Donovan JL; Garcia RL; Cliby WA; Dowdy SC
Int J Gynecol Pathol; 2015 Jan; 34(1):57-64. PubMed ID: 25473754
[TBL] [Abstract][Full Text] [Related]
31. IS "OVARIAN" CANCER A MISNOMER? EXPLORING OVARIAN CANCER ORIGINS IN THE MOUSE.
Cho KR
Trans Am Clin Climatol Assoc; 2018; 129():40-47. PubMed ID: 30166697
[TBL] [Abstract][Full Text] [Related]
32. Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma.
Novak M; Lester J; Karst AM; Parkash V; Hirsch MS; Crum CP; Karlan BY; Drapkin R
Gynecol Oncol; 2015 Oct; 139(1):104-11. PubMed ID: 26206555
[TBL] [Abstract][Full Text] [Related]
33. [The morphological and immunohistochemical characteristics of changes in the fallopian tube mucosa in ovarian epithelial tumors].
Asaturova AV; Ezhova LS; Faizullina NM; Sannikova MV; Khabas GN
Arkh Patol; 2016; 78(2):3-9. PubMed ID: 27070769
[TBL] [Abstract][Full Text] [Related]
34. Defining the molecular evolution of extrauterine high grade serous carcinoma.
Beirne JP; McArt DG; Roddy A; McDermott C; Ferris J; Buckley NE; Coulter P; McCabe N; Eddie SL; Dunne PD; O'Reilly P; Gilmore A; Feeney L; Ewing DL; Drapkin RI; Salto-Tellez M; Kennedy RD; Harley IJG; McCluggage WG; Mullan PB
Gynecol Oncol; 2019 Nov; 155(2):305-317. PubMed ID: 31493898
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.
Yamamoto Y; Ning G; Howitt BE; Mehra K; Wu L; Wang X; Hong Y; Kern F; Wei TS; Zhang T; Nagarajan N; Basuli D; Torti S; Brewer M; Choolani M; McKeon F; Crum CP; Xian W
J Pathol; 2016 Mar; 238(4):519-530. PubMed ID: 26415052
[TBL] [Abstract][Full Text] [Related]
36. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
[TBL] [Abstract][Full Text] [Related]
37. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
[TBL] [Abstract][Full Text] [Related]
38. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
39. Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.
Chui MH; Vang R; Wang TL; Shih IM; VandenBussche CJ
Cancer Cytopathol; 2019 Mar; 127(3):192-201. PubMed ID: 30861338
[TBL] [Abstract][Full Text] [Related]
40. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
